Objective:

To systematically evaluate the feasibility and clinical safety of Sonazoid in sentinel lymph node (SLN) identification for cutaneous malignant melanoma, comparing its performance with existing techniques.

Approach:

Key Findings:

• Remove subjective phrases like 'offers advantages' and ensure all findings are directly supported by the source.
• Consider rephrasing to focus on the observed results without editorializing.

Interpretation:

Remove this section as it includes unsupported conclusions.

Limitations:

• The study excluded patients with allergies to eggs and those who were pregnant or lactating.
• Results may not be generalizable to all melanoma patients due to specific inclusion criteria.

Conclusion:

Revise to avoid unsupported claims about enhancement and focus on findings directly stated in the source.

Source

Based on findings from:

Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma

Binbin Jiang, Liqi Sun, Lu Si, Jiayong Liu, Chuanliang Cui, Kun Yan, Shanshan Yin. European Radiology, 2026.

https://link.springer.com/article/10.1007/s00330-026-12640-2

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.